Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
2.035
+0.205 (11.20%)
Jun 29, 2026, 3:42 PM EDT - Market open
Aldeyra Therapeutics Employees
Aldeyra Therapeutics had 8 employees as of December 31, 2025. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$3,909,968
Market Cap
122.75M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 118 |
| Fractyl Health | 100 |
| enGene Therapeutics | 82 |
| Verrica Pharmaceuticals | 76 |
| PepGen | 59 |
| Vivani Medical | 42 |
| Aardvark Therapeutics | 40 |
| Oncolytics Biotech | 29 |
ALDX News
- 19 days ago - Aldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directors - Business Wire
- 25 days ago - Aldeyra Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 27 days ago - Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference - Business Wire
- 4 weeks ago - Shareholders Sue Aldeyra Therapeutics Over Dry Eye Drug Claims - TipRanks
- 7 weeks ago - Aldeyra Therapeutics Quarterly report: Q1 2026 - Filings
- 2 months ago - REMINDER: Aldeyra Therapeutics, Inc. Investors With Significant Losses Must Act By May 29, 2026 - GlobeNewsWire
- 2 months ago - Aldeyra Therapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Aldeyra Therapeutics Proxy statement: Proxy filing - Filings